Starr International Company’s AstraZeneca AZN Stock Holding History

Starr International Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-46,500	Closed	-$5.59M	–	4
2021 Q3	$5.59M	Hold	46,500	–	–	11.21%	3
2021 Q2	$5.57M	Hold	46,500	–	–	14.07%	3
2021 Q1	$4.62M	Hold	46,500	–	–	14.89%	3
2020 Q4	$4.65M	Hold	46,500	–	–	17.4%	3
2020 Q3	$5.1M	Buy	+46,500	New	+$5.17M	22.76%	2

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Starr International Company's AZN Position: Q4 2021 in Review

Starr International Company sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 46,500 shares — an estimated $5.59M sold.

Starr International Company first reported a position in AZN in Q3 2020 and held it in 5 quarters. The position peaked at $5.59M in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Starr International Company reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Starr International Company sold 46,500 AstraZeneca shares in Q4 2021, an estimated $5.59M.
Starr International Company first reported a position in AstraZeneca in Q3 2020 and held it in 5 quarters.
Starr International Company's AstraZeneca position peaked at $5.59M in Q3 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Starr International Company's 13F filing for Q4 2021, filed 27 Jan 2022.